News | Webinars | Publications | Conferences | Upcoming Events |
-
June 29, 2022
PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities -
March 15, 2022
GBR Connect Series – Interview with Emer Leahy, PsychoGenics -
January 25, 2022
PsychoGenics’ High Data Security Standards Are Certified by The NIH -
December 14, 2021
PsychoGenics Appoints Dr. Stephen Morairty as Vice President, Translational Neuroscience and Jean-Sebastien Valois as Vice President, Engineering and AI Development -
October 11, 2021
PsychoGenics Chief Innovation Officer Honored for Scientific Excellence -
September 25, 2020
PsychoGenics Further Strengthens its Leadership Team, Adding Three Senior Executives -
September 16, 2020
PsychoGenics Drug Discovery Featured in Nature Biopharma Dealmakers -
July 28, 2020
Karuna Therapeutics and PsychoGenics Announce Drug Discovery Collaboration -
November 6, 2019
PsychoGenics Awarded NIH HEAL Initiative Contract for Preclinical Screening Platform for Pain (PSPP)